CXCR3 anticorps (AA 1-326)

N° du produit ABIN7869194

Cet anticorps Lapin Polyclonal détecte spécifiquement CXCR3 dans WB, ELISA et IHC (p). Il présente une réactivité avec des échantillons de Souris et Rat.

Aperçu rapide pour CXCR3 anticorps (AA 1-326) (ABIN7869194)

Antigène: CXCR3 (Chemokine (C-X-C Motif) Receptor 3 (CXCR3))

Reactivité: Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CXCR3 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-CXCR3 anticorps

Épitope: AA 1-326

Fonction: Cxcr3 Antibody

Purification: Antigen affinity purified

Immunogène: Recombinant mouse protein (amino acids M1-E326) was used as the immunogen for the Cxcr3 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the Cxcr3 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the Cxcr3 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur CXCR3

Antigène: CXCR3 (Chemokine (C-X-C Motif) Receptor 3 (CXCR3))

Autre désignation: Cxcr3

Sujet: Chemokine receptor CXCR3 is a Galphai protein-coupled receptor in the CXC chemokine receptor family. Other names for CXCR3 are G protein-coupled receptor 9 (GPR9) and CD183. It is mapped to Xq13.1. CXCR3 is expressed on malignant B cells from chronic lymphoproliferative disorders, particularly in patients with CLL, and represents a fully functional receptor involved in chemotaxis of malignant B lymphocytes. It is found that in the absence of known etiologic agents, CXCR3 represents a novel target for therapeutic interference early in type 1 diabetes. CXCR3 signaling is associated with MG pathogenesis and proposed that and CXCR3 may serve as novel drug targets to treat MG. CXCR3A and CXCR3B are involved in the chemotactic and vascular effects of CXCL4L1.

UniProt: O88410